[LGND] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
27-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- 339.09%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 196,245 277,133 186,419 120,282 251,453 141,102 108,973 10.29%
PBT 36,011 47,298 -10,538 796,639 173,330 57,231 7,960 28.58%
Tax 41,230 -10,288 -7,553 167,337 30,009 44,675 10,327 25.93%
NP -5,219 57,138 -2,985 629,302 143,321 12,556 -1,636 21.31%
Tax Rate -114.49% 21.75% - -21.01% -17.31% -78.06% -129.74% -
Total Cost 201,464 219,995 189,404 -509,020 108,132 128,546 110,609 10.50%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -2.66 20.62 -1.60 523.19 57.00 8.90 -1.50 10.01%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.31 3.44 -0.18 33.13 5.96 0.60 -0.08 25.31%
EPS Diluted -0.31 3.31 -0.18 31.85 5.96 0.53 -0.08 25.31%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.